Format

Send to

Choose Destination
Sci Rep. 2015 Apr 13;5:9718. doi: 10.1038/srep09718.

Defining minimum essential factors to derive highly pure human endothelial cells from iPS/ES cells in an animal substance-free system.

Author information

1
Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
2
Laboratory Animal Center, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC.
3
Food Industry Research and Development Institute, Hsinchu, Taiwan, ROC.
4
Division of Infectious Diseases, National Health Research Institutes, Tainan, Taiwan, ROC.

Abstract

It is desirable to obtain unlimited supplies of endothelial cells for research and therapeutics. However, current methods of deriving endothelial cells from humans suffer from issues, such as limited supplies, contamination from animal substances, and lengthy/complicated procedures. In this article we developed a way to differentiate human iPS and ES cells to highly pure endothelial cells in 5 days. The chemically defined system is robust, easy to perform, and free of animal substances. Using the system, we verified that combined TGFβ and canonical Wnt agonists are essential and sufficient for iPS/ES cell-to-mesoderm transition. Besides, VEGF-KDR signaling alone is required for endothelial formation at high density while supplementation with FGF allows for colonial endothelial differentiation. Finally, anti-adsorptive agents could enrich the endothelial output by allowing selective attachment of the endothelial precursors. The system was validated to work on multiple iPS/ES cells lines to produce endothelial cells capable of forming capillary-like structures in vitro and integrating into host vasculature in vivo. In sum, the simple yet robust differentiation system permits the unlimited supply of human endothelial cells. The defined and animal substance-free nature of the system is compatible with clinical applications and characterization of endothelial differentiation in an unbiased manner.

PMID:
25864432
PMCID:
PMC4394195
DOI:
10.1038/srep09718
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center